We are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Our goal is to transform the treatment paradigm for patients suffering from these potentially life-threatening conditions for which there are no approved medicines or where existing approved medicines have limitations.
Looking for a particular Angion employee's phone or email?
The Angion annual revenue was $29.6 million in 2026.
Latha Paka is the Director, In-Vivo Pharmacology and Pre-Clinical Research of Angion.
7 people are employed at Angion.
Angion is based in Uniondale, New York.
The NAICS codes for Angion are [541, 3254, 54, 32, 325, 32541].
The SIC codes for Angion are [28, 873, 87, 283].